Results 131 to 140 of about 5,346,158 (173)

Isolated central nervous system involvement in blastic plasmacytoid dendritic cell neoplasm: a rare case of relapse during systemic remission with diagnostic and therapeutic implications. [PDF]

Front Oncol
Zhao H, Huang W, Lin S, Chen Y.
europepmc   +1 more source

Automated manufacturing of clinical-grade BDCA2 CAR NK cells in a closed system for the treatment of blastic plasmacytoid dendritic cell neoplasm. [PDF]

Front Immunol
Pfeifer R, Müller S, Nitsche M, Sohmen M, Kostyra J, Bister A, Bleilevens C, Brauner J, Mekes A, Raasch J, Lukas D, Kopatz J, Al Rawashdeh W, Mues M, Villacorta Hidalgo JA, Huppert V, Assenmacher M, Möker N, Orentas R, Zhang C.   +19 more
europepmc   +1 more source

Venetoclax combined with azacitidine for treatment of a blastic plasmacytoid dendritic cell neoplasm: A case report and literature review. [PDF]

Exp Ther Med
Lai Y, Chen X, Zhou H.
europepmc   +1 more source

Genetic characteristics of blastic plasmacytoid dendritic cell neoplasm: A single institution experience. [PDF]

Oncotarget
Fei F, Telatar M, Tomasian V, Chang L, Danilova O, Arias-Stella J, Pillai R, Soma L, Tizro P, Becker PS, Stein AS, Marcucci G, Afkhami M.   +12 more
europepmc   +1 more source

Care Optimization for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm Receiving Tagraxofusp. [PDF]

J Adv Pract Oncol
Faysman K, Rubin J, Lubas A, Kujawa T, Hinojosa G, Marx KR, Katsetos J, Galinsky IA.   +7 more
europepmc   +1 more source

Healthcare Resource Utilization and Treatment Costs for Blastic Plasmacytoid Dendritic Cell Neoplasm: A PETHEMA Study. [PDF]

Cancers (Basel)
Solana-Altabella A, Navarro-Vicente I, Rodríguez-Arbolí E, Noriega V, Serrano J, Bernal T, Carrasco-Baraja V, Garcia-Boyero R, Olivier Cornacchia C, Algarra L, López-Briz E, Mena-Durán A, Solano-Tovar J, Botella-Prieto C, Sánchez-Sánchez S, Bergua-Burgues JM, Lloret-Madrid P, Rodenas-Rovira M, Boluda B, Cano-Ferri I, Acuña-Cruz E, Rodríguez-Veiga R, Torres-Miñana L, Centelles-Oria M, Poveda-Andrés JL, Martínez-Cuadrón D, Montesinos P.   +26 more
europepmc   +1 more source

First-line tagraxofusp leads to durable responses and prolonged survival in adults with blastic plasmacytoid dendritic cell neoplasm regardless of fitness level. [PDF]

Haematologica
Pemmaraju N, Herling M, Sweet KL, Stein AS, Vasu S, Rosenblat TL, Rizzieri DA, Papayannidis C, Wang ES, Konopleva M, Zuurman M, Tosolini A, Qazilbash M, Lane AA.   +13 more
europepmc   +1 more source

Blastic plasmacytoid dendritic cell neoplasm secondary to acute myeloid leukemia with shared mutations in TET2 and DNMT3A: a case report and literature review. [PDF]

Front Immunol
Sun Y, Liu Y, Liu N, Zhang X, Huang W, Hu L.   +5 more
europepmc   +1 more source

Multi-organ single-cell analysis reveals PLD4 as a biomarker and potential therapeutic target of blastic plasmacytoid dendritic cell neoplasm. [PDF]

Cancer Cell Int
Wang M, Xue X, Wang Z, Wang C, Yu G, Mi Z, Sang X, Wang J, Liu Y, Chen X, Chen S, Zhou G, Liu H, Chen H, Sun Y, Zhang F.   +15 more
europepmc   +1 more source

Clinico-hematopathologic and Genetic Characteristics of Korean Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm: A Retrospective Single-Center Cohort Study. [PDF]

Ann Lab Med
Kim J, Kim M, Chu D, Cho YU, Hwang SH, Jang S, Seo EJ, Choi EJ, Park HS, Lee JH, Lee JH, Yoon DH, Go H, Park CS, Lee KH, Park CJ, Hwang S.   +16 more
europepmc   +1 more source